ZA964B - Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples - Google Patents

Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples

Info

Publication number
ZA964B
ZA964B ZA964A ZA964A ZA964B ZA 964 B ZA964 B ZA 964B ZA 964 A ZA964 A ZA 964A ZA 964 A ZA964 A ZA 964A ZA 964 B ZA964 B ZA 964B
Authority
ZA
South Africa
Prior art keywords
monoclonal antibodies
biological samples
antibodies specific
advanced glycosylation
glycosylation endproducts
Prior art date
Application number
ZA964A
Inventor
Henry W Founds
Homayoun Sadeghi
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alteon Inc filed Critical Alteon Inc
Publication of ZA964B publication Critical patent/ZA964B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA964A 1994-12-30 1996-01-02 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples ZA964B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/367,507 US5744318A (en) 1994-12-30 1994-12-30 Monoclonal antibody for the detection of advanced glycosylation endproducts in biological samples

Publications (1)

Publication Number Publication Date
ZA964B true ZA964B (en) 1996-10-02

Family

ID=23447463

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964A ZA964B (en) 1994-12-30 1996-01-02 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples

Country Status (2)

Country Link
US (3) US5744318A (en)
ZA (1) ZA964B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3356556B2 (en) * 1993-10-22 2002-12-16 第一化学薬品株式会社 Method for measuring denatured lipoproteins
US6033862A (en) * 1996-10-30 2000-03-07 Tokuyama Corporation Marker and immunological reagent for dialysis-related amyloidosis, diabetes mellitus and diabetes mellitus complications
JP3541352B2 (en) * 2000-06-09 2004-07-07 アークレイ株式会社 Selective complex of lipoprotein and hemoglobin or hemoglobin analog, assay using the complex, and assay kit
ATE283481T1 (en) * 2001-03-22 2004-12-15 Hoffmann La Roche METHOD FOR FINDING REAGENTS AND SOLID PHASE COMPONENTS IN SPECIFIC BINDING ASSAY, FREE OF ADVANCED GLYCOSYLATION END PRODUCTS
EP1243924B1 (en) * 2001-03-22 2004-11-24 Boehringer Mannheim Gmbh Method for the selection of reagents and solid phase components in specific binding assays free of advanced glycosylation endproducts
AU2002259142A1 (en) * 2002-05-03 2003-11-17 Thomas Jefferson University Method to follow progression of kidney disease
US20110105961A1 (en) * 2008-05-23 2011-05-05 Gruber Lewis S Methods, compositions and apparatuses for facilitating regeneration
ES2725852T3 (en) 2010-09-27 2019-09-27 Siwa Corp Selective removal of AGE modified cells for the treatment of atherosclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
WO2012135616A1 (en) * 2011-03-31 2012-10-04 Siwa Corporation Vaccination against advanced glycation end-products
ES2908203T3 (en) 2014-09-19 2022-04-28 Siwa Corp Anti-aging antibodies for the treatment of inflammation and autoimmune disorders
US10358502B2 (en) * 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
RU2728964C2 (en) 2016-02-19 2020-08-03 Сива Корпорейшн Method and composition for treating cancer, destroying metastatic cancer cells and preventing metastases of cancer, using antibodies to end products of increased glycation (age)
CN109311975A (en) 2016-04-15 2019-02-05 Siwa有限公司 For treating the anti-AGE antibody of neurodegenerative disorder
US11213585B2 (en) 2016-06-23 2022-01-04 Siwa Corporation Vaccines for use in treating various diseases and disorders
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
CA3059803A1 (en) 2017-04-13 2018-10-18 Siwa Corporation Humanized monoclonal advanced glycation end-product antibody
US11518801B1 (en) * 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869534A (en) * 1992-05-21 1999-02-09 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
US5624804A (en) * 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products

Also Published As

Publication number Publication date
US5744318A (en) 1998-04-28
US5698197A (en) 1997-12-16
US5766590A (en) 1998-06-16

Similar Documents

Publication Publication Date Title
ZA964B (en) Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
EP0708334A3 (en) Reagent and method for analyzing solid components in urine
HUT74828A (en) Anti-alpha-v-integrin monoclonal antibody
AU696947B2 (en) Monoclonal antibody to oncofetal protein for treating and detecting cancer
HUP0003451A3 (en) Method and device for withdrawing biological samples
NZ236000A (en) Oligomeric monoclonal igg antibody composition
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
AU4556699A (en) Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
GB9511752D0 (en) Protein biosensor and method for protein measurement
EP0745849A3 (en) Sample processing method for whole blood
AU5407994A (en) Method for particulate reagent sample treatment
EP0750185A3 (en) Element and system for collecting, transporting and saving analytical samples
AU1734195A (en) Analysis system for liquid samples
GB9513586D0 (en) Sample analyzer
EP0795027A4 (en) Method for in vitro protein synthesis
EP0909278A4 (en) Nephropathy-related immunoglobulin g and antibodies for same
EP0419081A3 (en) Method for protein binding enzyme complementation assays
EP0472593A4 (en) Method for protein binding enzyme complementation assays
GB9520787D0 (en) Blood sample analysis
GB2286671B (en) Preparation of samples for kerogen analysis
EP0761687A4 (en) Process for preparing antibody
GB2278195B (en) Immunoassay for analytes in samples using alkylating agents
EP0431171A4 (en) Monoclonal antibody against c-reactive protein
GB9513300D0 (en) Estimating grain size in geological samples
AU4745996A (en) Method for measuring hormones in biological samples